Health Care & Life Sciences Summit

Events

Financial Times US Health Care & Life Sciences Summit

Navigating the shift to value

Bringing together providers, payers, industry executives, patient representatives, and investors, the Summit will focus on emerging industry trends and will highlight the challenges and opportunities that market disruptions, political changes, and digital innovations will create for the health care and life sciences industry. May 12, 2016 | Metropolitan Club | New York, NY USA

Executive summary

The US health care industry is in the midst of the largest transformation in its history. Silos are dissolving and synergies evolving. Organizations are partnering, affiliating, and consolidating at record rates. Value based care and outcomes based pricing are becoming a reality across the industry, and various consumer and digital savvy players from the world of retail and food to consumer electronics are entering the healthcare realm and transforming the competitive landscape of the industry. How will the future unfold?

Topics to be covered:

  • Health care and politics: Obamacare and beyond-What will the election mean for health care in the US?
  • Drug pricing: The dawn of a new era?
  • Better together? How will consolidation and convergence transform the health care industry?
  • Value gets real: Navigating the shift to value based care and outcomes based pricing
  • What’s next for digital health?

Visit the conference website at live.ft.com/USHCLS to learn more about the speakers, agenda, the topics to be covered, and to register. Please use marketing code FTDEL to receive 25 percent off the current registration rate.

Topics to be covered

  • U.S. health care reform: Risk and opportunity in the new health economy
  • What is the price of a drug?
  • MACRA and beyond: How value is transforming the business model of the industry
  • Is the future of healthcare virtual? Prospects for home care and telehealth
  • Tackling the social determinants of health: The next big challenge
  • Managing the cost of diabetes care: Front line perspectives
  • Skills and leadership for the new health economy: The healthcare workforce of the 21st century
  • Beyond genomics: Harnessing innovation on the frontiers of science and technology

Confirmed speakers

  • Heather Bresch, Chief Executive Officer, Mylan 
  • Dieter Weinard, President and Chairman of the Board, Bayer Pharma AG
  • Tanisha Carino, Vice President, US Public Policy, GlaxoSmithKline
  • Mario Schlosser, CEO & Co-Founder, Oscar
  • Daniel Barchi, Chief Information Officer, New York Presbyterian Hospital
  • Peter Keeling, Chief Executive Officer, Diaceutics
  • Anne Phelps, Principal, US Healthcare Regulatory Leader, Deloitte
  • Sarah Thomas, Managing Director, Deloitte Center for Health Solutions, Deloitte
  • Robert Henkel, President and Chief Executive Officer, Ascension Health
  • David Blumenthal, President, The Commonwealth Fund
  • Noubar Afeyan, Senior Managing Partner and CEO, Flagship Pioneering
  • Josh Bruno, Founder and CEO, Hometeam
  • Steve Cutler, CEO, ICON
  • Jeffrey Dachis, Founder and CEO, One Drop
  • The Honorable Tom Daschle, Founder and CEO, The Daschle Group
  • Damon Francis, Chief Medical Officer, Health Leads
  • Dedi Gilad, CEO, Tyto Care
  • Douglas Henley, Executive Vice President and Chief Executive Officer, American Academy of Family Physicians
  • Aaron Kesselheim, Associate Professor of Medicine, Harvard Medical School
  • Michelle Larkin, Associate Vice President and Associate Chief of Staff, Robert Wood Johnson Foundation
  • David Lansky, Chief Executive Officer, Pacific Business Group on Health
  • Jeff Marrazzo, CEO, Spark Therapeutics
  • Jim Meyers, Executive Vice President, Worldwide Commercial Operations, Gilead
  • Steve Miller, Vice President and Chief Medical Officer, Express Scripts
  • Michael Rea, Founder and CEO, Rx Savings Solutions
  • Roy Schoenberg, CEO, American Well
  • Ramita Tandon, Executive Vice President, Commercialization and Outcomes, ICON

Confirmed speakers

  • Alex Gorsky, chairman and CEO, Johnson & Johnson
  • Stefano Pessina, executive vice chairman and chief executive officer, Walgreens Boots Alliance
  • Dr. Thomas Frieden, director, Centers for Disease Control and Prevention
  • Dr. Mitch Morris, Global Life Sciences and Health Care leader, Deloitte
  • David Cutler, Otto Eckstein Professor of Applied Economics, Harvard University
  • Chris Gordon, managing director, Healthcare, Bain Capital
  • Anne Phelps, US Life Sciences and Health Care Regulatory leader, Deloitte
  • Jeff Myers, president and CEO, Medicaid Health Plans of America
  • Sarah Emond, chief operating officer, Institute for Clinical and Economic Review (ICER)
  • Dr. Peter Bach, director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
  • Kenneth L. Davis, president and CEO, Mount Sinai Health System
  • Scott Gottlieb, Resident Scholar, American Enterprise Institute
  • Sachin Jain, chief medical officer, CareMore Health System; Consulting Professor, Stanford University School of Medicine
  • Laura Kaiser, executive vice president and chief operating officer, Intermountain Healthcare
  • David Miller, senior vice president, Global Market Access, Biogen
  • Harold Miller, president and CEO, Center for Health Quality and Payment Reform
  • Ron Gutman, president and CEO, HealthTap
  • Amy Landucci, Global Head Digital Medicines, Novartis
  • Demetrius Maraganore, Medical director, Neurological Institute, NorthShore University Health System
  • Bruno Villetelle, chief digital officer, Takeda Pharmaceutical Company Limited
  • Daphne Zohar, Co-founder and chief executive officer, PureTech
financial times, deloitte health care and life sciences summit, event

Meet the speakers

Anne Phelps

Anne Phelps

Principal|US Health Care Regulatory Leader

A Principal with Deloitte & Touche LLP. Anne has more than twenty-four years of health care policy experience having worked in federal agencies, the US Senate, the White House and in consulting firms.... More